Fortrea is a contract research organization that provides clinical trial management, patient access, and related development services to pharmaceutical, biotechnology, and medical-device companies.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Louis Bacon / Moore | 56 | New buy | 70,723 | $666,211 | 0.0% |
| Keith Meister / Corvex | 69 | Added +3% | 4,644,193 | $43,748,298 | 1.7% |
| Ancora | 42 | Holds (flat) | 3,391 | $31,943 | 0.0% |
| Report | Date | Stance |
|---|---|---|
| #110 — I Can See Clearly Now... The Rain Is Gone? | 2025-11-03 | LONG |
| #84 — Market Memo: Healthcare's AI-Powered Trump Card | 2025-02-09 | LONG |
| #80 — Market Memo: January Musings | 2025-01-09 | LONG |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.